Diastole Medical is revolutionizing coronary diagnostics with AI-powered, non-invasive Doppler ultrasound analysis to detect what’s often missed.
Diastole Medical is revolutionizing coronary diagnostics with AI-powered, non-invasive Doppler ultrasound analysis to detect what’s often missed.
Diastole Medical is revolutionizing coronary diagnostics with AI-powered, non-invasive Doppler ultrasound analysis to detect what’s often missed.
0M+
0M+
With CAD Worldwide
0.0%
0.0%
CMD in non-obstructive CAD
0x
0x
Higher CV Risk
The Solution
The Diastole Solution
The Solution
The Diastole Solution
The Solution
The Diastole Solution
Holistic Coronary View
Visualizes flow dynamics across the entire coronary tree
Holistic Coronary View
Visualizes flow dynamics across the entire coronary tree
Holistic Coronary View
Visualizes flow dynamics across the entire coronary tree
Rapid Results
Actionable insights in seconds, right at the point of care
Rapid Results
Actionable insights in seconds, right at the point of care
Rapid Results
Actionable insights in seconds, right at the point of care
Seamless Integration
Works with existing echocardiography systems
Seamless Integration
Works with existing echocardiography systems
Seamless Integration
Works with existing echocardiography systems
Our Advantage
Transforming Care at Every Level
Our Advantage
Transforming Care at Every Level
Uncovering the Undiagnosed
Helping millions get proper management and close the gap.
Lowering Unnecessary Interventions
Up to 60% of angiographies are diagnostic-only and potentially avoidable.
CMD Unlocked
New, wildly available technology to detect previously missed conditions and improve CV care.
Economic Impact
Reducing unnecessary procedures and hospitalizations, saving billions in healthcare costs.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
I spent months in hospitals with chest pain no one could explain. Every test came back normal, yet I kept ending up in the ER. When I was finally diagnosed with coronary microvascular dysfunction, it was a turning point. I finally knew why I felt this way, and the uncertainty and endless testing stopped.
Poullete P.
My angiogram looked clear, but I still couldn’t climb a flight of stairs without exhaustion. Dr. James said I was lucky to get the CMD diagnosis in time. It probably saved my heart.
Linda M.
When my chest pain turned out to be coronary artery disease and I received a stent, I thought the hardest part was behind me. But the real challenge was the uncertainty that followed. Luckily, the yearly checkups now give me confidence that everything is still under control.
Greg T.
The Platform
The Diastole Advantage
Stakeholders
The Diastole Stakeholders
Stakeholders
The Diastole Stakeholders
Stakeholders
The Diastole Stakeholders
01
Healthcare Providers
Empower clinicians with AI-driven echocardiography that enables precise, non-invasive detection and diagnosis of CAD and CMD at any point of care.
01
Healthcare Providers
Empower clinicians with AI-driven echocardiography that enables precise, non-invasive detection and diagnosis of CAD and CMD at any point of care.
01
Healthcare Providers
Empower clinicians with AI-driven echocardiography that enables precise, non-invasive detection and diagnosis of CAD and CMD at any point of care.
02
Ultrasound Vendors
Integrating non-invasive coronary diagnostic tools, transforms traditional Ultrasound systems into advanced, AI-enhanced platforms.
02
Ultrasound Vendors
Integrating non-invasive coronary diagnostic tools, transforms traditional Ultrasound systems into advanced, AI-enhanced platforms.
02
Ultrasound Vendors
Integrating non-invasive coronary diagnostic tools, transforms traditional Ultrasound systems into advanced, AI-enhanced platforms.
03
Medical Insurance
Enables cost reduction and improved coding accuracy by identifying CMD early. Reducing unnecessary caths and generating higher reimbursement efficiency.
03
Medical Insurance
Enables cost reduction and improved coding accuracy by identifying CMD early. Reducing unnecessary caths and generating higher reimbursement efficiency.
03
Medical Insurance
Enables cost reduction and improved coding accuracy by identifying CMD early. Reducing unnecessary caths and generating higher reimbursement efficiency.
04
Medical Device companies
Establishes a clear pathway for identifying patients eligible for medical device interventions.
04
Medical Device companies
Establishes a clear pathway for identifying patients eligible for medical device interventions.
03
Medical Insurance
Enables cost reduction and improved coding accuracy by identifying CMD early. Reducing unnecessary caths and generating higher reimbursement efficiency.
05
Pharmaceutical industries
Expands dramatically the CMD research and guided therapy markets.
05
Pharmaceutical industries
Expands dramatically the CMD research and guided therapy markets.
04
Medical Device companies
Establishes a clear pathway for identifying patients eligible for medical device interventions.
Contact
Get in Touch
Contact
Get in Touch
